AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$188.52
+2.52%Margins
Gross margin
80.1%
EBITDA margin
34.4%
EBIT margin
23.7%
Net margin
17.7%
FCF margin
15.0%
21.3%
Return on equity
9.2%
Return on assets
17.1%
Return on invested capital
0.53x
Asset turnover
$13.3B
Cash from operations
$5.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026